Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nurses take the lead: could nurse-led methadone dosing keep more people in treatment?

NCT ID NCT07085377

Disease control Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study tests a new approach where nurses, rather than doctors, adjust methadone doses for people starting treatment for opioid addiction. The goal is to see if this makes it easier for patients to stay in care for at least three months. The trial will enroll 182 adults in French addiction centers and compare the nurse-led method to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
methadone
What this could lead to
If successful, this could make methadone treatment more accessible and flexible, helping more people stay in care for opioid addiction.
What could go wrong
This is a small, early-stage study in France, so results may not apply elsewhere. The approach relies on nurse training and local regulations, which may limit broader use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 182 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject 18 years of age or older, * With opioid use disorder (OUD) according to DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) criteria (other authorized psychoactive substance use), * Intending to start methadone treatment for OUD in a CSAPA center within 7 days, * Agreeing to be followed up in a CSAPA over the next 3 months, Exclusion Criteria: * Having taken methadone treatment (on prescription) in the three months prior to inclusion, * Simultaneous medical care in another addictology facility, * with a day-hospital project, * Referral to town prescriber or town pharmacy planned and/or requested by patient before 3 month, * Non-stabilized psychiatric disorder or cognitive impairment likely to compromise compliance and involvement in care (at investigator's discretion), * Inability to communicate and express themselves in French language, * Subject to a legal protection measure other than curatorship, * Pregnant or breast-feeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Addictology are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Addictology Opioid use disorder (OUD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CSAPA de Brioude

    NOT_YET_RECRUITING

    Brioude, 43100, France

  • CSAPA du Griffon, Oppelia Aria 69

    RECRUITING

    Villeurbanne, 69100, France

  • CSAPA, Association Bizia, Centre Hospitalier de la Côte Basque

    RECRUITING

    Bayonne, 64109, France

  • CSAPA, Association Nationale de Prévention en Alcoologie et Addictologie (ANPAA), Résidence Le Victor Hugo

    NOT_YET_RECRUITING

    Le Puy-en-Velay, 43000, France

  • CSAPA, Hôpital de la Croix Rousse, Hospices Civils de Lyon

    RECRUITING

    Lyon, 69004, France

  • CSAPA, Service Universitaire d'Addictologie de Lyon, Hôpital Edouard Herriot, Hospices Civils de Lyon

    RECRUITING

    Lyon, 69003, France

  • CSAPA, Service d'Addictologie, Centre Hospitalier Charles Perrens, CHU de Bordeaux

    NOT_YET_RECRUITING

    Bordeaux, 33000, France

  • CSAPA, Service de Psychiatrie et d'Addictologie, Hôpital Civil, CHRU de Strasbourg

    NOT_YET_RECRUITING

    Strasbourg, 690910, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.